Andrew Sinclair
CIK 1762451 · last filed 2026-06-23
Andrew Sinclair is a corporate insider who has filed 34 SEC Form 4 insider transactions across 6 companies since 2018. The most recent filing, for ACET, was dated Jun 23, 2026. Across all open-market trades the lifetime net is +$33.8M, making them a net buyer over the disclosed history. Current disclosed insider exposure totals $1.1M across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$1.09M
6
34
$33.78M
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| ACET | Director | 133,318 | $8.20 | $1.09M | $14.00M | 11 | 2026-06-23 |
| SOLENO THERAPEUTICS INC (SLNO) Delisted | Director | 1,201,507 | $53.01 | $63.69M | $5.50M | 11 | 2026-05-18 |
| NCNA | Director | — | $1.29 | — | $0 | 1 | 2024-08-23 |
| Sierra Oncology, Inc. (SRRA) Delisted | Director | 0 | $54.99 | $0 | $4.05M | 7 | 2022-07-01 |
| Verona Pharma plc (VRNA) Delisted | Director | — | $106.91 | — | $0 | 1 | 2021-08-10 |
| SOLENO THERAPEUTICS INC (SLNOW) Delisted | Director | 6,969,272 | — | — | $10.23M | 3 | 2019-10-29 |
Recent Filings
34 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-06-23 | ACET | Grant (A) | — | $0 | EDGAR |
| 2026-05-18 | SOLENO THERAPEUTICS INC (SLNO) Delisted | Disp (D) | −10,491 | $0 | EDGAR |
| 2025-06-13 | ACET | Grant (A) | +5,900 | $0 | EDGAR |
| 2025-06-09 | SOLENO THERAPEUTICS INC (SLNO) Delisted | Grant (A) | +3,991 | $0 | EDGAR |
| 2024-08-23 | NCNA | Mixed | — | $0 | EDGAR |
| 2024-06-10 | SOLENO THERAPEUTICS INC (SLNO) Delisted | Grant (A) | +6,500 | $0 | EDGAR |
| 2024-06-07 | ACET | Grant (A) | +5,900 | $0 | EDGAR |
| 2023-08-16 | ACET | Mixed | — | $0 | EDGAR |
| 2023-06-02 | ACET | Grant (A) | +5,900 | $0 | EDGAR |
| 2023-05-26 | SOLENO THERAPEUTICS INC (SLNO) Delisted | Grant (A) | — | $0 | EDGAR |
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.